Bvf Inc Intra Cellular Therapies, Inc. Transaction History

Bvf Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 07, 2018	SELL	$15.16 - $25.49 $4.14 Million - $6.97 Million	-273,350 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$14.27 - $16.79 $9.66 Million - $11.4 Million	-676,650 Reduced 71.23%	273,350 $3.96 Million
Q3 2017 Nov 14, 2017	BUY	$10.77 - $22.1 $10.2 Million - $21 Million	950,000	950,000 $15 Million

378

84.1M

319K

143K

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $7.86B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

Get notified when there are updates to the investment portfolio of Bvf Inc, based on Form 13F filings with the SEC.

Stay updated on Bvf Inc with notifications on news.